Recent News

• 03.09.2026 - Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
• 02.23.2026 - Cartesian Therapeutics to Participate in Upcoming Investor Conferences
• 02.03.2026 - Cartesian Therapeutics Announces New Employment Inducement Grants
• 01.09.2026 - Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook
• 01.06.2026 - Cartesian Therapeutics Announces New Employment Inducement Grants

Recent Filings

• 03.09.2026 - EX-99.1 EX-99.1
• 03.09.2026 - 8-K Current report
• 03.09.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.05.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.13.2026 - 144 Report of proposed sale of securities
• 01.09.2026 - 8-K Current report
• 01.09.2026 - 144 Report of proposed sale of securities
• 01.09.2026 - EX-99.1 EX-99.1
• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities